MIRA INFORM REPORT

 

 

Report Date :

02.04.2013

 

IDENTIFICATION DETAILS

 

Name :

IMI CO LTD

 

 

Registered Office :

3-3-12 Ryutsudanchi Koshigaya Saitama-Pref 343-0824

 

 

Country :

Japan

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

May 1974

 

 

Com. Reg. No.:

0300-01-063447

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Import, wholesale of medical equipment

 

 

No. of Employees :

198

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

Regular

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

 

japan - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A tiny agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. Usually self-sufficient in rice, Japan imports about 60% of its food on a caloric basis. Japan maintains one of the world's largest fishing fleets and accounts for nearly 15% of the global catch. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2011 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2011. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan further into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake in March disrupted manufacturing. Electricity supplies remain tight because Japan has temporarily shut down almost all of its nuclear power plants after the Fukushima Daiichi nuclear reactors were crippled by the earthquake and resulting tsunami. Estimates of the direct costs of the damage - rebuilding homes, factories, and infrastructure - range from $235 billion to $310 billion, and GDP declined almost 0.5% in 2011. Prime Minister Yoshihiko NODA has proposed opening the agricultural and services sectors to greater foreign competition and boosting exports through membership in the US-led Trans-Pacific Partnership trade talks and by pursuing free-trade agreements with the EU and others, but debate continues on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.

 

 

Source : CIA

 

 

 

 


Company name and address

 

IMI CO LTD

REGD NAME:    IMI KK

MAIN OFFICE:  3-3-12 Ryutsudanchi Koshigaya Saitama-Pref 343-0824 JAPAN

Tel: 048-988-4411     Fax: 048-961-1350     -

 

URL:                 http://www.imimed.co.jp

E-Mail address: support@imimed.co.jp

 

 

ACTIVITIES  

 

Import, wholesale of medical equipment

 

 

BRANCHES   

 

Tokyo, Sapporo, Sendai, Yokohama, Kobe, other (Tot 14)

 

 

OVERSEAS   

 

USA, Europe, other (--partners)

 

 

FACTORIES  

 

At the caption address

 

 

CHIEF EXEC

 

KAZUMASA TSUMUGA, PRES

 

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY    

 

FINANCES        FAIR                 A/SALES          Yen 7,937 M

PAYMENTS      REGULAR         CAPITAL           Yen 1,111 M

TREND             UP                    WORTH            Yen 11,564 M

STARTED         1974                 EMPLOYES      198

 

 

COMMENT    

 

TRADING FIRM SPECIALIZING IN MIDICAL EQUIPMENT 

FINANCIAL SITUATION COSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.

           

 

Unit: In Million Yen

Forecast figures for the 321/12/2013 fiscal term.

 

 

HIGHLIGHTS

 

This is an importer and distributor of medical equipment, including artificial aspirators and anesthesia equipment.  Also engaged in production of such equipment, and leasing & maintenance services.  Sells to universities and hospitals.  Goods are imported from Europe, USA, other.

 

 

FINANCIAL INFORMATION

 

            The sales volume for Dec/2012 fiscal term amounted to Yen 7,937 million, a 1% up from Yen 7,862 million in the previous term.   The recurring profit was posted at Yen 1,798 million and the net profit at Yen 1,003 million, respectively, compared with Yen 1,701 million recurring profit and Yen 934 million net profit, respectively, a year ago. 

           

            For the current term ending Dec 2013 the recurring profit is projected at Yen 1,720 million and the net profit at Yen 965 million, on a 20% rise in turnover, to Yen 9,500 million. 

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered: May 1974

Regd No.:         0300-01-063447 (Saitama-Koshigaya)

Legal Status:      Limited Company (Kabushiki Kaisha

Authorized:       20 million shares

Issued:                5.71 million

Sum:                   Yen 1,111 million

 

Major shareholders (%): Tsumuga Management (25.9), Company’s Treasury Stock (8.5), MUFG (2.6), Employees’ S/Holding Assn (1.9), Tokio Marine & Nichido Fire Ins (1.7), Akihiro Matsubara (1.2), Yasumitsu Shigeta (1.1), Skandinaviska Enskilda B Clients (1.0), Mutsuaki Imura (1.0); foreign owners (3.0)

 

No. of shareholders: 1,749

 

Listed on the S/Exchange (s) of: JASDAQ

 

Managements: Kazumasa Tsumuga, ch & pres; Moro Akio, mgn dir; Koji Kojima, dir; Yuji Suga, dir,

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Imports and wholesales medical equipment: Life support systems (18%), life data measuring & monitoring systems (6%), purchased products (24%), rental (28%), maintenance (17%)

 

(Handling Items): lung ventilators & accessories, anesthesia machines & accessories, surgical equipment, infusion/syringe pumps, other.

           

Clients: [Universities, hospitals] Yagami Co, Ino Mediccs, Konishi Medical Instruments, Kyowa Medical Corp, other

No. of accounts: 500

Domestic areas of activities: Nationwide

Suppliers: [Mfrs, wholesalers] Products are imported from: ResMed Ltd (Austria),Southmedic Inc (Canada), Ambu A/S, Dameca s/s (Denmark), Airox, Mallinkrodt Developmetn France, Taema (France), MedutekHandelsgeselschaft FurMedizintechnik GmbH, Salvia Lifetec GmbH (Germany), Flaem Houva spa (Italy), Fisher & Paykel Healthcare Ltd (New Zealand), Anmedic AB (Sweden), Acutronic Medical Systems AG, IMT Mieical ag, Radiometer Basel AG (Switz), nSpire Health Ltd, Integra Nurse Science Ltd, Medivent Ltd, Panlon Ltd, SMS (UK), Arisep Corp, Allied Healthcare Products Inc, Cardinal Health Inc, Clynical Dynamic Corp, Life-Tec Ins, other (--USA)

 

Payment record: Regular

 

Location: Business area in Saitama-Pref.  Office premises at the caption address are owned maintained satisfactorily.

 

Bank References:

MUFG (Kasukabe & Ueno)

Relations: Satisfactory

 

 

 

 

 

 

FINANCES

 

(In Million Yen)

FINANCES: (Consolidated in million yen)

 

 

 

Terms Ending:

31/12/2012

31/12/2011

INCOME STATEMENT

 

 

 

  Annual Sales

 

7,937

7,862

 

  Cost of Sales

3,945

3,937

 

      GROSS PROFIT

3,991

3,925

 

  Selling & Adm Costs

2,215

2,270

 

      OPERATING PROFIT

1,776

1,655

 

  Non-Operating P/L

22

46

 

      RECURRING PROFIT

1,798

1,701

 

      NET PROFIT

1,003

934

BALANCE SHEET

 

 

 

 

  Cash

 

7,401

6,350

 

  Receivables

 

1,177

1,219

 

  Inventory

 

601

717

 

  Securities, Marketable

599

296

 

  Other Current Assets

549

526

 

      TOTAL CURRENT ASSETS

10,327

9,108

 

  Property & Equipment

1,463

1,541

 

  Intangibles

 

79

109

 

  Investments, Other Fixed Assets

1,971

2,109

 

      TOTAL ASSETS

13,840

12,867

 

  Payables

 

535

354

 

  Short-Term Bank Loans

 

 

 

 

 

 

 

 

  Other Current Liabs

1,139

1,155

 

      TOTAL CURRENT LIABS

1,674

1,509

 

  Debentures

 

 

 

 

  Long-Term Bank Loans

 

 

 

  Reserve for Retirement Allw

474

475

 

  Other Debts

 

128

123

 

      TOTAL LIABILITIES

2,276

2,107

 

      MINORITY INTERESTS

 

 

 

Common stock

164

164

 

Additional paid-in capital

1,233

1,233

 

Retained earnings

9,927

9,237

 

Evaluation p/l on investments/securities

(63)

(174)

 

Others

 

949

946

 

Treasury stock, at cost

(646)

(646)

 

      TOTAL S/HOLDERS` EQUITY

11,564

10,760

 

      TOTAL EQUITIES

13,840

12,867

CONSOLIDATED CASH FLOWS

 

 

 

 

Terms ending:

31/12/2012

31/12/2011

 

Cash Flows from Operating Activities

 

1,695

1,679

 

Cash Flows from Investment Activities

168

-329

 

Cash Flows from Financing Activities

-312

-312

 

Cash, Bank Deposits at the Term End

 

7,901

6,350

ANALYTICAL RATIOS            Terms ending:

31/12/2012

31/12/2011

 

 

Net Worth (S/Holders' Equity)

11,564

10,760

 

 

Current Ratio (%)

616.91

603.58

 

 

Net Worth Ratio (%)

83.55

83.62

 

 

Recurring Profit Ratio (%)

22.65

21.64

 

 

Net Profit Ratio (%)

12.64

11.88

 

 

Return On Equity (%)

8.67

8.68

 

           


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.38

UK Pound

1

Rs.82.32

Euro

1

Rs.69.54

 

 

INFORMATION DETAILS

 

Report Prepared by :

PDT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.